Annual EPS
-$24.75
+$0.25+1.00%
December 31, 2022
Summary
- As of February 10, 2025, AGLE annual earnings per share is -$24.75, with the most recent change of +$0.25 (+1.00%) on December 31, 2022.
- During the last 3 years, AGLE annual EPS has risen by +$36.50 (+59.59%).
Performance
AGLE EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$9.34
+$47.41+83.54%
September 30, 2023
Summary
- As of February 10, 2025, AGLE quarterly earnings per share is -$9.34, with the most recent change of +$47.41 (+83.54%) on September 30, 2023.
- Over the past year, AGLE quarterly EPS has dropped by -$4.50 (-92.98%).
Performance
AGLE Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$75.67
-$4.50-6.32%
September 30, 2023
Summary
- As of February 10, 2025, AGLE TTM earnings per share is -$75.67, with the most recent change of -$4.50 (-6.32%) on September 30, 2023.
- Over the past year, AGLE TTM EPS has dropped by -$47.08 (-164.67%).
Performance
AGLE TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
AGLE EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.0% | -93.0% | -164.7% |
| 3 y3 years | +59.6% | -28.8% | -58.5% |
| 5 y5 years | +45.0% | +30.8% | -23.5% |
AGLE EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1.0% | +103.9% | +507.6% | +257.4% | at low |
| 5 y | 5-year | at high | +147.5% | +273.6% | +507.6% | +257.4% | at low |
| alltime | all time | at high | +147.5% | +273.6% | +507.6% | +1258.1% | at low |
Aeglea BioTherapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$9.34(-83.5%) | -$75.67(+6.3%) |
| Jun 2023 | - | -$56.75(+1035.0%) | -$71.17(+236.2%) |
| Mar 2023 | - | -$5.00(+9.2%) | -$21.17(-16.7%) |
| Dec 2022 | -$24.75(-1.0%) | -$4.58(-5.4%) | -$25.42(-11.1%) |
| Sep 2022 | - | -$4.84(-28.3%) | -$28.59(-9.2%) |
| Jun 2022 | - | -$6.75(-27.0%) | -$31.50(+15.6%) |
| Mar 2022 | - | -$9.25(+19.4%) | -$27.25(+9.0%) |
| Dec 2021 | -$25.00(-34.2%) | -$7.75(0.0%) | -$25.00(-2.9%) |
| Sep 2021 | - | -$7.75(+210.0%) | -$25.75(+2.0%) |
| Jun 2021 | - | -$2.50(-64.3%) | -$25.25(-22.9%) |
| Mar 2021 | - | -$7.00(-17.6%) | -$32.75(-18.1%) |
| Dec 2020 | -$38.00(-38.0%) | -$8.50(+17.2%) | -$40.00(-16.2%) |
| Sep 2020 | - | -$7.25(-27.5%) | -$47.75(-16.2%) |
| Jun 2020 | - | -$10.00(-29.8%) | -$57.00(-6.2%) |
| Mar 2020 | - | -$14.25(-12.3%) | -$60.75(-0.8%) |
| Dec 2019 | -$61.25(+15.0%) | -$16.25(-1.5%) | -$61.25(+0.4%) |
| Sep 2019 | - | -$16.50(+20.0%) | -$61.00(+5.2%) |
| Jun 2019 | - | -$13.75(-6.8%) | -$58.00(+4.0%) |
| Mar 2019 | - | -$14.75(-7.8%) | -$55.75(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$53.25(+18.3%) | -$16.00(+18.5%) | -$53.25(+13.9%) |
| Sep 2018 | - | -$13.50(+17.4%) | -$46.75(+3.3%) |
| Jun 2018 | - | -$11.50(-6.1%) | -$45.25(-0.5%) |
| Mar 2018 | - | -$12.25(+28.9%) | -$45.50(+1.1%) |
| Dec 2017 | -$45.00(-18.9%) | -$9.50(-20.8%) | -$45.00(+2.9%) |
| Sep 2017 | - | -$12.00(+2.1%) | -$43.75(+0.6%) |
| Jun 2017 | - | -$11.75(0.0%) | -$43.50(+0.6%) |
| Mar 2017 | - | -$11.75(+42.4%) | -$43.25(+4.4%) |
| Dec 2016 | -$55.50(+120.2%) | -$8.25(-29.8%) | -$41.45(-1.1%) |
| Sep 2016 | - | -$11.75(+2.2%) | -$41.92(-1.8%) |
| Jun 2016 | - | -$11.50(+15.6%) | -$42.68(+17.2%) |
| Mar 2016 | - | -$9.95(+14.0%) | -$36.41(+0.2%) |
| Dec 2015 | -$25.20(-33.5%) | -$8.72(-30.3%) | -$36.35(-7.5%) |
| Sep 2015 | - | -$12.51(+139.2%) | -$39.29(+1.5%) |
| Jun 2015 | - | -$5.23(-47.1%) | -$38.69(-8.4%) |
| Mar 2015 | - | -$9.88(-15.2%) | -$42.24(+11.4%) |
| Dec 2014 | -$37.93 | -$11.66(-2.1%) | -$37.93(+44.4%) |
| Sep 2014 | - | -$11.91(+35.6%) | -$26.27(+83.0%) |
| Jun 2014 | - | -$8.78(+57.6%) | -$14.35(+157.6%) |
| Mar 2014 | - | -$5.57 | -$5.57 |
FAQ
- What is Aeglea BioTherapeutics annual earnings per share?
- What is the all time high annual EPS for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics annual EPS year-on-year change?
- What is Aeglea BioTherapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics quarterly EPS year-on-year change?
- What is Aeglea BioTherapeutics TTM earnings per share?
- What is the all time high TTM EPS for Aeglea BioTherapeutics?
- What is Aeglea BioTherapeutics TTM EPS year-on-year change?
What is Aeglea BioTherapeutics annual earnings per share?
The current annual EPS of AGLE is -$24.75
What is the all time high annual EPS for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high annual earnings per share is -$24.75
What is Aeglea BioTherapeutics annual EPS year-on-year change?
Over the past year, AGLE annual earnings per share has changed by +$0.25 (+1.00%)
What is Aeglea BioTherapeutics quarterly earnings per share?
The current quarterly EPS of AGLE is -$9.34
What is the all time high quarterly EPS for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high quarterly earnings per share is -$2.50
What is Aeglea BioTherapeutics quarterly EPS year-on-year change?
Over the past year, AGLE quarterly earnings per share has changed by -$4.50 (-92.98%)
What is Aeglea BioTherapeutics TTM earnings per share?
The current TTM EPS of AGLE is -$75.67
What is the all time high TTM EPS for Aeglea BioTherapeutics?
Aeglea BioTherapeutics all-time high TTM earnings per share is -$5.57
What is Aeglea BioTherapeutics TTM EPS year-on-year change?
Over the past year, AGLE TTM earnings per share has changed by -$47.08 (-164.67%)